Literature DB >> 2471348

Treatment of drusen-related aging macular degeneration by photocoagulation.

P C Wetzig.   

Abstract

This retrospective clinical study of the treatment of DR AMD by scatter pattern photocoagulation reveals a stabilization of vision and disappearance of drusen in 52% of 42 eyes followed for an average of 3 years. With the minimal risks involved, the benefit of temporary improvement or stabilization of vision in some eyes would make this technique worthy of further evaluation.

Entities:  

Mesh：

Year:  1988        PMID： 2471348      PMCID： PMC1298809     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN： 0065-9533


  17 in total

1.  Exudative senile maculopathy. I. Results of argon laser treatment.

Authors:  H Schatz; A Patz
Journal:  Arch Ophthalmol       Date:  1973-09

2.  Drusen and disciform macular detachment and degeneration.

Authors:  J D Gass
Journal:  Arch Ophthalmol       Date:  1973-09

3.  New vessel formation beneath the retinal pigment epithelium in senile eyes.

Authors:  S H Sarks
Journal:  Br J Ophthalmol       Date:  1973-12       Impact factor: 4.638

4.  Photocoagulation of macular lesions.

Authors:  J D Gass
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1971 May-Jun

5.  Laser photocoagulation of macular lesions.

Authors:  H C Zweng; H L Little; R R Peabody
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1968 May-Jun

6.  Photocoagulation of exudative senile maculopathy.

Authors:  G W Cleasby; W E Fung; J V Fiore
Journal:  Arch Ophthalmol       Date:  1971-01

7.  Pathologic features of senile macular degeneration.

Authors:  W R Green; P J McDonnell; J H Yeo
Journal:  Ophthalmology       Date:  1985-05       Impact factor: 12.079

8.  Photocoagulation of exudative senile maculopathy. A followup report.

Authors:  G W Cleasby; W E Fung; J L Norris
Journal:  Trans Pac Coast Otoophthalmol Soc Annu Meet       Date:  1974

9.  Disciform degeneration of the macula. II. Pathogenesis.

Authors:  E S Gragoudas; S R Chandra; E Friedman; M L Klein; M Van Buskirk
Journal:  Arch Ophthalmol       Date:  1976-05

10.  Senile macular degeneration and geographic atrophy of the retinal pigment epithelium.

Authors:  D Willerson; T M Aaberg
Journal:  Br J Ophthalmol       Date:  1978-08       Impact factor: 4.638
View more
  7 in total

1.  Influence of laser photocoagulation on choroidal capillary cytoarchitecture.

Authors:  R H Guymer; G S Hageman; A C Bird
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

Review 2.  Statement and supplementary statement from the BVA, the DOG, and the RG on laser treatment of drusen in age-related macular degeneration (AMD) : August 2017, update October 2018.

Authors: 
Journal:  Ophthalmologe       Date:  2020-01       Impact factor: 1.059

Review 3.  [Statement from the BVA, the DOG and the RG on laser treatment of drusen in age-related macular degeneration (AMD) : August 2017].

Authors: 
Journal:  Ophthalmologe       Date:  2017-11       Impact factor: 1.059

Review 4.  Prophylactic laser in age-related macular degeneration: the past, the present and the future.

Authors:  Quan Findlay; Andrew I Jobling; Kirstan A Vessey; Ursula Greferath; Joanna A Phipps; Robyn H Guymer; Erica L Fletcher
Journal:  Eye (Lond)       Date:  2018-03-09       Impact factor: 3.775

Review 5.  Laser photocoagulation as treatment of non-exudative age-related macular degeneration: state-of-the-art and future perspectives.

Authors:  Giuseppe Querques; Maria Vittoria Cicinelli; Alessandro Rabiolo; Luigi de Vitis; Riccardo Sacconi; Lea Querques; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-25       Impact factor: 3.117

6.  Photocoagulation of drusen-related macular degeneration: a long-term outcome.

Authors:  P C Wetzig
Journal:  Trans Am Ophthalmol Soc       Date:  1994

Review 7.  Subthreshold Nano-Second Laser Treatment and Age-Related Macular Degeneration.

Authors:  Amy C Cohn; Zhichao Wu; Andrew I Jobling; Erica L Fletcher; Robyn H Guymer
Journal:  J Clin Med       Date:  2021-01-28       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.